Tula, Tula, Russian Federation
UDK 61 Медицина. Охрана здоровья
The article is devoted to chronic thromboembolic pulmonary hypertension, the mechanisms of its development, the features of its diagnosis and specific treatment. As an illustration, a clinical case of chronic thromboembolic pulmonary hypertension is presented in a patient with repeatedly recurrent pulmonary embolisms against the background of chronic thrombophlebitis of the veins of the lower extremities, breast cancer and chemotherapy. The importance of timely diagnosis of the disease under discussion and determining the correct tactics for managing such patients to improve their prognosis and survival are outlined.
chronic thromboembolic pulmonary hypertension, pulmonary embolism, chronic cor pulmonale, PAH-specific therapy
1. Rezuhina E.A., Martynyuk T.V., Valieva Z.S., Gramovich V.V., Chazova I.E. Legochnaya arterial'naya gipertenziya: vyzovy i dostizheniya 2021 // Evraziyskiy kardiologicheskiy zhurnal. 2022. №. 1 (37). S. 80-89.
2. Valerio L., Mavromanoli A.S., Barco S., Abele C., Becker D., Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study // European Heart Journal. 2022. T. 43. №. 36. S. 3387-3398.
3. Cannon J. E., Jenkins D. P., Hoole S. P. Chronic thromboembolic pulmonary hypertension: a review of risk factors, management and current challenges // Expert Review of Cardiovascular Therapy. 2022. T. 20. №. 1. S. 35-43.
4. Chazova I.E., Karabasheva M.B., Danilov N.M., Matchin Yu.G. Hronicheskaya tromboembolicheskaya legochnaya gipertenziya: sovremennyy vzglyad na problemu // Kardiologicheskiy vestnik. 2019. T. 14. №. 2. S. 14-23.
5. Rekomendacii ESC po diagnostike i lecheniyu ostroy legochnoy embolii, razrabotannye v sotrudnichestve s Evropeyskim respiratornym obschestvom (ERS), 2019, nauchnoe redaktirovanie perevoda vypolneno: direktorom instituta serdca i sosudov FGBU “NMIC im. V.A. Almazova” Minzdrava Rossii, d.m.n. Moiseevoy O.M. // Rossiyskiy kardiologicheskiy zhurnal 2020; 25 (8).
6. Klinkova A.S., Kamenskaya O.V., Loginova I.Yu., Chernyavskiy A.M., Edemskiy A.G. Rezul'taty trehletnego nablyudeniya i ocenka kachestva zhizni posle trombendarterektomii iz legochnoy arterii // Rossiyskiy kardiologicheskiy zhurnal. 2020. №. 8. S. 36-40.
7. Martynyuk T. V., Nakonechnikov S. N., Chazova I. E. Na puti optimizacii podhodov k lecheniyu hronicheskoy tromboembolicheskoy legochnoy gipertenzii // Consilium Medicum. 2016. T. 18. №. 5. S. 53-58.
8. Martynyuk T.V., Shmalts A.A., Gorbachevsky S.V., Chazova E.I. Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat // Terapevticheskii arkhiv. 2021. T. 93. №. 9. S. 1117-1124.
9. Rezuhina E. A., Rodnenkov O. V., Martynyuk T. V. Primenenie agonista receptorov prostaciklina seleksipaga u pacientki s idiopaticheskoy legochnoy gipertenziey vysokogo riska: klinicheskiy sluchay // Kardiovaskulyarnaya terapiya i profilaktika. 2021. T. 20. №. 5. S. 92-98.
10. Rezuhina E.A., Martynyuk T.V., Valieva Z.S., Gramovich V.V., Chazova I.E. Legochnaya arterial'naya gipertenziya: vyzovy i dostizheniya 2021 // Evraziyskiy kardiologicheskiy zhurnal. 2022. №. 1 (37). S. 80-89.
11. Chazova I. E., Yarovoy S. Yu., Danilov N. M. Evolyuciya patogeneticheskoy terapii legochnoy arterial'noy gipertenzii // Terapevticheskiy arhiv. 2019. T. 91. №. 12. S. 4-12.
